India’s Growing Immuno-Oncology
India has emerged as a dominant player in the global biosimilar and generic drugs market. The country is now eyeing a greater share in the …
Unleashing Industry Insights, Connecting the Future
India has emerged as a dominant player in the global biosimilar and generic drugs market. The country is now eyeing a greater share in the …
Immune checkpoint inhibitors (ICIs) have revolutionized the treatment of many lethal cancers. However, only a small percentage of patients benefit from this therapy. Therefore, it …